Literature DB >> 10550303

Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up.

W J Melchers1, J M Bakkers, J Wang, P C de Wilde, H Boonstra, W G Quint, A G Hanselaar.   

Abstract

The purpose of this study was to detect and genotype 16 different human papilloma virus (HPV) types simultaneously using a short fragment polymerase chain reaction (SPF) hybridization line probe assay (LiPA). 152 women who were referred to the gynecologist because of abnormal cervical smear underwent colposcopic examination and repeat cervical smear. In addition, the cervical scrapes were analyzed for the presence of HPV by a novel general HPV polymerase chain reaction assay followed by a single reaction genotyping assay allowing for a simultaneous detection and identification of 16 different HPV types. HPV DNA was detected in 38% of normal follow-up cervical scrapes, 51% of scrapes with atypical squamous cells of undetermined significance, 78% of scrapes with mild dysplasia (low grade squamous intraepithelial lesions), 86% of scrapes with moderate dysplasia (high grade squamous intraepithelial lesions), and in 88% of scrapes with severe dysplasia and carcinoma in situ. One case of invasive squamous cell carcinoma was positive for HPV 16. Overall, a single HPV type was detected in 56% of HPV positive scrapes, with HPV 16 being the most common and accounting for 45% of all single infections. Forty-four percent of the positive scrapes contained multiple HPV types, of which double infections prevailed. Follow-up results proved the reproducibility and reliability of SPF HPV LiPA. In conclusion, we have used and evaluated the SPF-HPV-LiPA system for the detection and genotyping of HPV infections. The combined detection-typing method proved to be sensitive, specific, simple, and fast, making mass screening of cervical scrapes accessible for routine practice and facilitating individual patient management.

Entities:  

Mesh:

Year:  1999        PMID: 10550303      PMCID: PMC1866998          DOI: 10.1016/S0002-9440(10)65462-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Strategies for global control of cervical cancer.

Authors:  J Pontén; H O Adami; R Bergström; J Dillner; L G Friberg; L Gustafsson; A B Miller; D M Parkin; P Sparén; D Trichopoulos
Journal:  Int J Cancer       Date:  1995-01-03       Impact factor: 7.396

2.  Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy.

Authors:  S Y Chan; H Delius; A L Halpern; H U Bernard
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

3.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

4.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

5.  Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.

Authors:  M E Sherman; M H Schiffman; A T Lorincz; M M Manos; D R Scott; R J Kuman; N B Kiviat; M Stoler; A G Glass; B B Rush
Journal:  Am J Clin Pathol       Date:  1994-08       Impact factor: 2.493

6.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

7.  The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.

Authors:  A J Remmink; J M Walboomers; T J Helmerhorst; F J Voorhorst; L Rozendaal; E K Risse; C J Meijer; P Kenemans
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396

8.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

9.  Human papillomavirus testing in primary cervical screening.

Authors:  J Cuzick; A Szarewski; G Terry; L Ho; A Hanby; P Maddox; M Anderson; G Kocjan; S T Steele; J Guillebaud
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

10.  Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.

Authors:  J M Walboomers; A M de Roda Husman; P J Snijders; H V Stel; E K Risse; T J Helmerhorst; F J Voorhorst; C J Meijer
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

View more
  27 in total

1.  Lower Genital Tract Infections and HIV in Women.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.

Authors:  Maaike A P C van Ham; Judith M J E Bakkers; Gonneke K Harbers; Wim G V Quint; Leon F A G Massuger; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.

Authors:  Sally N Adebamowo; Adebowale A Adeyemo
Journal:  Hum Immunol       Date:  2019-05-06       Impact factor: 2.850

4.  Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women.

Authors:  Romy van Baars; Remko P Bosgraaf; Bram W A ter Harmsel; Willem J G Melchers; Wim G V Quint; Ruud L M Bekkers
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

5.  Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.

Authors:  Dennis van Hamont; Maaike A P C van Ham; Judith M J E Bakkers; Leon F A G Massuger; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil.

Authors:  José E Levi; Bernhard Kleter; Wim G V Quint; Maria C S Fink; Cynthia L M Canto; Regina Matsubara; Iara Linhares; Aluísio Segurado; Bart Vanderborght; José Eluf Neto; Leen-Jan Van Doorn
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy.

Authors:  Paola Menegazzi; Luisa Barzon; Giorgio Palù; Elisa Reho; Luigi Tagliaferro
Journal:  Infect Dis Obstet Gynecol       Date:  2010-01-24

8.  No high-risk HPV detected in SCC of the oral tongue in the absolute absence of tobacco and alcohol--a case study of seven patients.

Authors:  T J H Siebers; M A W Merkx; P J Slootweg; W J G Melchers; P van Cleef; P C M de Wilde
Journal:  Oral Maxillofac Surg       Date:  2008-12

9.  Sequencing-based genotyping of mixed human papillomavirus infections by use of RipSeq software.

Authors:  Keith D Tardif; Keith E Simmon; Oyvind Kommedal; Michael T Pyne; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

10.  Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities.

Authors:  R P de Bie; H P van de Nieuwenhof; R L M Bekkers; W J G Melchers; A G Siebers; J Bulten; L F A G Massuger; J A de Hullu
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.